Online citations, reference lists, and bibliographies.
← Back to Search

A Comprehensive Review On Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, And Future Challenges

Suvarna P. Phadatare, M. Momin, Premanand A Nighojkar, Sonali S. Askarkar, K. Singh
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Dry eye syndrome (DES) or keratoconjunctivitis sicca (KCS) is a common disorder of the tear film caused by decreased tear production or increased evaporation and manifests with a wide variety of signs and symptoms. The present review from interpretation of the literature gives detailed information on the prevalence, definition, causes, diagnostic tests, and medical management of dry eye disease. A number of systems contribute to the physiological integrity of the ocular surface and disruption of system may or may not produce symptoms. Therefore accurate diagnosis of dry eyes with no or minimal disruption of physiological function is necessary. The paper also discusses different colloidal drug delivery systems and current challenges in the development of topical ophthalmic drug delivery systems for treatment of KCS. Due to the wide prevalence and number of factors involved, newer, more sensitive diagnostic techniques and novel therapeutic agents have been developed to provide ocular delivery systems with high therapeutic efficacy. The aim of this review is to provide awareness among the patients, health care professionals, and researchers about diagnosis and treatment of KCS and recent developments and future challenges in management of dry eye disease.
This paper references
Ocular Drug Delivery
B. Gilger (2016)
10.1016/0169-409X(95)00016-Z
Liposome ocular delivery systems
D. Meisner (1995)
10.1159/000131069
Classification and diagnosis of dry eye.
T. Kaercher (2008)
10.1016/S1542-0124(12)70148-9
Inflammation in dry eye.
M. Stern (2004)
10.1016/S1542-0124(12)70214-8
Essential fatty acids in the treatment of dry eye.
E. S. Rosenberg (2010)
10.1016/S0039-6257(00)00201-0
Diagnosis of dry eye.
A. Bron (2001)
10.1097/ICO.0000000000000038
A Review of Quality of Life Measures in Dry Eye Questionnaires
Joseph Grubbs (2014)
10.1007/978-1-4615-0717-8_55
Androgen regulation of lipogenesis.
J. Swinnen (2002)
10.1159/000099263
Regulatory T cells and the eye.
J. Niederkorn (2007)
10.1038/sj.eye.6700566
Tears in health and disease
J. Tiffany (2003)
10.1016/S0002-9394(14)71688-5
Prevalence of dry eye among the elderly.
O. Schein (1997)
10.1001/ARCHOPHT.1992.01080160106043
Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects.
G. Berdy (1992)
10.1016/S0161-6420(97)30125-0
Relation between signs and symptoms of dry eye in the elderly. A population-based perspective.
O. Schein (1997)
10.1016/j.ajo.2010.10.032
Tear osmolarity in the diagnosis and management of dry eye disease.
M. Lemp (2011)
Rose bengal staining and expression of mucin-like glycoprotein in cornea epithelium
H. Watanabe (1996)
10.1001/ARCHOPHT.118.9.1264
Prevalence of and risk factors for dry eye syndrome.
S. Moss (2000)
10.1038/eye.2010.67
Impact of symptomatic dry eye on vision-related daily activities: The Singapore Malay Eye Study
L. Tong (2010)
10.1016/s1542-0124(12)70082-4
The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007).
J. Smith (2007)
10.1097/00006324-199701000-00014
Importance of the Lipid Layer in Human Tear Film Stability and Evaporation
J. Craig (1997)
Non-toxic ophthalmic preparations and methods of preparing them
J. P. Gilbard (1991)
10.1001/archophthalmol.2009.103
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies.
D. Schaumberg (2009)
10.1016/S0002-9394(03)00203-4
Abnormal protein profiles in tears with dry eye syndrome.
Y. Ohashi (2003)
10.1038/eye.2010.7
Tear proteomics in evaporative dry eye disease
P. Versura (2010)
10.1016/j.sjopt.2014.06.004
Essential fatty acids in the treatment of dry eye syndrome: A myth or reality?
Ammar M. Al Mahmood (2014)
10.1016/j.jconrel.2011.12.016
Cyclosporin pro-dispersion liposphere formulation.
A. Avramoff (2012)
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.
M. Lemp (1995)
10.2147/OPTH.S1496
The challenge of dry eye diagnosis
G. Savini (2008)
10.1136/bjo.83.1.89
Diseases associated with ocular surface abnormalities: the importance of reflex tearing
K. Tsubota (1999)
10.1167/iovs.11-8829
A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
C. Di Tommaso (2012)
Advances in understanding andmanaging dry eye disease
D. A. Schaumberg (2008)
10.1007/3-540-29662-x_915
Dry Eye Syndrome
M. Javadi (2011)
An epidemiologic study of medication use and symptoms of dry eye
O. Schein (1997)
10.1001/ARCHOPHT.116.7.849
Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality.
W. Shine (1998)
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
A. Solomon (2001)
10.1016/j.ajo.2013.10.014
Dry eye disease and work productivity loss in visual display users: the Osaka study.
M. Uchino (2014)
Study of human precorneal tear film thickness and structure using laser interferometry.
J. Prydal (1992)
Ophthalmic conditions
W. S. Pray (2006)
Dry eye disease compounds currently under evaluation in clinical trials
B. Colligris (2014)
10.1038/eye.1989.64
The ocular surface in keratoconjunctivitis sicca
A. Bron (1989)
10.1016/S1542-0124(12)70096-4
Isolation of the ocular surface to treat dysfunctional tear syndrome associated with computer use.
R. Yee (2007)
10.4103/0301-4738.16170
Dry eye: prevalence and attributable risk factors in a hospital-based population.
A. Sahai (2005)
10.1016/S0014-4835(03)00203-3
The lipid layer of tears: dependent on meibomian gland function.
J. Mcculley (2004)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1097/00003226-199801000-00007
Evaluation of Subjective Assessments and Objective Diagnostic Tests for Diagnosing Tear‐Film Disorders Known to Cause Ocular Irritation
S. Pflugfelder (1998)
10.1007/BF01204791
Tear mucus ferning in patients with Sjögren's syndrome
E. Vaikoussis (2005)
10.1016/j.ajo.2013.12.023
Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life.
A. Paulsen (2014)
Ophthalmic solution with tetracycline for topical treatment of dry eye disease
J. P. Gilbard (1999)
10.1016/j.jconrel.2008.12.018
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
R. C. Nagarwal (2009)
Ophthalmic preparations Tear secretion — a short review
K. Colby (2014)
10.1016/j.sjopt.2013.12.003
Recent developments on dry eye disease treatment compounds
B. Colligris (2014)
10.3109/02652048709021825
Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres.
A. Yanagawa (1987)
10.1016/j.ijpharm.2008.07.028
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
E. Gokce (2008)
10.1016/s1542-0124(12)70083-6
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007).
A. Bron (2007)
10.1155/2014/781683
Aging: A Predisposition to Dry Eyes
A. Sharma (2014)
The diagnosis andmanagement of dry eye : a twenty - five - year review
A. A. Afonso (2000)
10.1097/00003226-200210000-00007
Use of the Dry Eye Questionnaire to Measure Symptoms of Ocular Irritation in Patients With Aqueous Tear Deficient Dry Eye
C. Begley (2002)
Prevalence and treatment ofHelicobacter pylori in patientswith blepharitis
S. C. Sacca (2006)
10.1111/J.1600-0722.2004.00183.X
Sjögren's syndrome.
N. Delaleu (2005)
10.1007/978-3-642-31028-7_1
The Mucus in the Preocular Tear Film
H. Tabery (2012)
10.1001/ARCHOPHT.118.5.615
Reliability and validity of the Ocular Surface Disease Index.
R. Schiffman (2000)
10.1016/B978-1-4557-2876-3.00003-1
3 – The Tear Film: Anatomy, Structure and Function
J. B. Foster (2013)
10.1001/JAMA.286.17.2114
Hormone replacement therapy and dry eye syndrome.
D. A. Schaumberg (2001)
10.2147/OPTH.S39061
Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models
Atsuyoshi Dota (2013)
10.1001/archopht.126.8.1046
Evaluation of topical cyclosporine for the treatment of dry eye disease.
H. Perry (2008)
10.1159/000309895
Tear function parameters in keratoconjunctivitis sicca with and without the association of Sjögren's syndrome.
A. Mackor (1988)
10.1016/j.jtos.2014.02.002
Rethinking dry eye disease: a perspective on clinical implications.
A. Bron (2014)
Safety study of lifitegrast to treat dry eye (SONATA)
C. Semba (1636)
10.4172/2153-0769.1000105
Biomarker Identification of Tear Fluid
F. Tsuji (2012)
Ophthalmic preparations.
M. Phillips (1982)
10.1007/978-1-4615-0717-8_38
Mucins and ocular surface disease.
Sawako H Hibino (2002)
10.1016/J.AJO.2005.05.025
Correlation between dry eye and rheumatoid arthritis activity.
Miho Fujita (2005)
10.1097/00003226-200009000-00009
The Diagnosis and Management of Dry Eye: A Twenty-five–Year Review
S. Pflugfelder (2000)
10.1016/S0002-9394(00)00620-6
Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome.
M. Balaram (2001)
10.1016/J.ADDR.2005.07.005
The use of mucoadhesive polymers in ocular drug delivery.
A. Ludwig (2005)
10.1007/BF00137949
Clinical profiles of non dry eye patients and correlations with tear protein levels
C. Snyder (2004)
10.1016/j.ajo.2008.05.016
Advances in understanding and managing dry eye disease.
M. Lemp (2008)
10.1097/00055735-200408000-00004
Dry eye diagnosis and management in 2004
H. Perry (2004)
10.1159/000267188
Diagnostic tests for dry eye disease in normals and dry eye patients with and without Sjögren's syndrome.
G. Petroutsos (1992)
10.1089/JOP.1994.10.29
Microparticulates for ophthalmic drug delivery.
A. Joshi (1994)
10.1007/978-1-4615-0717-8_157
Alternative reference values for tear film break up time in normal and dry eye populations.
M. Abelson (2002)
10.1016/j.ophtha.2012.06.064
Improving awareness, identification, and management of meibomian gland dysfunction.
G. Foulks (2012)
10.1016/J.SURVOPHTHAL.2005.02.008
Computer vision syndrome: a review.
C. Blehm (2005)
10.1136/bjo.2004.044347
Autologous serum eye drops for ocular surface disorders
G. Geerling (2004)
Tear secretion—a short review
J. Lakshmi Prabha (2014)
10.1016/S0162-3109(00)00192-2
Mechanisms of action of cyclosporine.
S. Matsuda (2000)
10.1016/j.preteyeres.2004.04.003
Changes in the tear film and ocular surface from dry eye syndrome
M. E. Johnson (2004)
10.1097/00003226-200404000-00010
The Repeatability of Clinical Measurements of Dry Eye
K. Nichols (2004)
Therapeutic targets in dry eye syndrome.
A. Peral (2008)
10.1201/B14144-15
Therapy of Lacrimal Keratoconjunctivitis
S. Pflugfelder (2004)
10.1016/j.ophtha.2009.11.029
Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial.
I. Avni (2010)
10.1007/978-1-4615-0717-8_140
Epidemiology of dry eye syndrome.
D. A. Schaumberg (2002)
10.1016/0002-9394(78)90177-0
Topical retinoic acid in the treatment of corneal xerophthalmia.
A. Sommer (1978)
10.1016/S1350-9462(97)00002-5
Ophthalmic drug delivery systems—Recent advances
C. L. Bourlais (1998)
10.1016/J.AJO.2006.11.060
Impact of dry eye syndrome on vision-related quality of life.
Biljana Miljanović (2007)
10.2165/00002512-200825020-00003
Pharmacological Management of Dry Eye in the Elderly Patient
G. N. Foulks (2008)
10.1016/J.EXER.2003.09.020
Non-invasive methods of assessing the tear film.
N. Yokoi (2004)
10.1167/IOVS.05-0323
Prevalence and treatment of Helicobacter pylori in patients with blepharitis.
S. Saccà (2006)
10.1007/s12325-012-0033-9
Diquafosol Ophthalmic Solution for Dry Eye Treatment
M. Nakamura (2012)
10.1097/00003226-200310000-00008
Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests
A. Bron (2003)
10.5301/EJO.2008.4293
The triple classification of dry eye for practical clinical use.
J. Murube (2005)
10.1167/IOVS.05-1504
Tear film osmolarity: determination of a referent for dry eye diagnosis.
A. Tomlinson (2006)
10.1016/J.EXER.2003.09.003
The role of the lacrimal functional unit in the pathophysiology of dry eye.
M. Stern (2004)
10.1111/j.1475-1313.2011.00834.x
Computer vision syndrome: a review of ocular causes and potential treatments
M. Rosenfield (2011)
10.1016/S0039-6257(96)80064-6
Meibomian gland dysfunction.
P. Driver (1996)
10.1001/ARCHINTE.164.12.1275
Clinical manifestations and early diagnosis of Sjögren syndrome.
S. Kassan (2004)
10.1016/J.EXER.2003.09.009
Impression cytology of the ocular surface: a review.
M. Calonge (2004)
10.1016/S0161-6420(99)90170-7
Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
A. A. Afonso (1999)
10.1097/01.ico.0000176611.88579.0a
Efficacy of Commercially Available Topical Cyclosporine A 0.05% in the Treatment of Meibomian Gland Dysfunction
H. Perry (2006)
Why dry eye trials often fail
P. M. Karpecki (2013)
10.1159/000310101
Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study.
M. Rolando (1990)
Investigative Ophthalmology and Visual Science
C. Frey (2010)
10.1001/ARCHOPHT.118.11.1489
Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.
K. S. Kunert (2000)
10.1016/j.ophtha.2012.04.010
Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Y. Matsumoto (2012)
10.1159/000027504
A Survey of Trachoma: The Histopathology and the Mechanism of Progressive Cicatrization of Eyelid Tissues
M. Guzey (2000)
Prevalence, burden, and pharmacoeconomics of dry eye disease.
S. Pflugfelder (2008)
10.1016/s1542-0124(12)70081-2
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).
Michael A. Lemp (2007)
10.1006/EXER.1998.0520
Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva.
J. Jumblatt (1998)
10.1136/bjo.82.1.88
CA 19-9 ELISA test: a new method for studying mucus changes in tears
C. Garcher (1998)
10.1016/S0084-392X(09)79161-0
Topical Omega-3 and Omega-6 Fatty Acids for Treatment of Dry Eye
K. Hammersmith (2009)
10.1155/2014/683153
Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh (2014)
10.1089/JOP.1994.10.83
Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations.
M. Saettone (1994)
10.1159/ISBN.978-3-318-01404-4
Immune Response and the Eye
J. Niederkorn (2007)
10.1097/00003226-199905000-00015
Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells.
J. Kim (1999)
10.1016/J.AJO.2004.02.010
Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
M. Ono (2004)
The tear film
E. Peters (2006)
10.1016/j.ophtha.2012.12.022
A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
S. Kinoshita (2013)
10.3109/02713688508999960
A non-invasive instrument for clinical assessment of the pre-corneal tear film stability.
L. S. Mengher (1985)
10.1016/j.sjopt.2014.06.002
Dry eye disease: A review of diagnostic approaches and treatments.
H. Lin (2014)
10.1093/AJCN/82.4.887
Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women.
Biljana Miljanović (2005)
A COMPARATIVE REVIEW OF RECENTLY DEVELOPED PARTICULATE DRUG CARRIER SYSTEMS
Raju Manda (2014)
10.1097/00006324-198004000-00008
Tear Film Physiology
F. Holly (1987)
10.1167/iovs.10-6997a
The international workshop on meibomian gland dysfunction: executive summary.
K. Nichols (2011)



This paper is referenced by
10.5005/jp-journals-10064-0022
Clinical Safety of Selected Ayurvedic Formulations in Common Eye Diseases
Babita Yadav (2017)
10.12680/balneo.2020.340
The impact of the dry eye syndrome on the quality of life in elderly patients-minireview
C. Nicula (2020)
Knowledge and Practice Regarding Dry Eye among General Population in Western Region of Saudi Arabia
Reem Mohammed Kalakattawi (2018)
Sodium Fluorescein Staining of the Cornea for the Diagnosis of Dry Eye: A Comparison of Three Eye Solutions
M. Chen (2017)
10.1109/EMBC.2019.8856492
An Eye-tracking based Evaluation on the Effect of Far-infrared Therapy for Relieving Visual Fatigue
Y. Feng (2019)
10.1039/d0cc02200d
Nanogel receptors for high isoelectric point protein detection: influence of electrostatic and covalent polymer-protein interactions.
Marissa E. Wechsler (2020)
10.3390/s17051158
Development towards Compact Nitrocellulose-Based Interferometric Biochips for Dry Eye MMP9 Label-Free In-Situ Diagnosis
B. Santamaría (2017)
10.36295/asro.2020.231038
Dry Eye Disease among Medical Students at the University of Fallujah, Iraq
Rafea Allawi Fayyadh (2020)
10.2147/OPTH.S201127
The acute effect of a single dose of green tea on the quality and quantity of tears in normal eye subjects
A. Masmali (2019)
A Comparative Clinical Trial on the Sustained Effect of Topical Application of Durva Ghritam against Artificial Tear Drops/Eye Ointments in Dry Eye-A Retrospective Study
Sreeja Sukesan (2018)
10.1117/12.2288257
Development towards compact nitrocellulose interferometric biochips for dry eye diagnosis based on MMP9, S100A6 and CST4 biomarkers using a Point-of-Care device
B. Santamaría (2018)
10.1016/j.ab.2017.11.014
Contact lens to measure individual ion concentrations in tears and applications to dry eye disease.
R. Badugu (2018)
10.1186/s12886-018-0869-0
Assessment of meibomian glands using a custom–made meibographer in dry eye patients in Ghana
E. A. Osae (2018)
10.1111/jjns.12165
Nurses can play an active role in the early diagnosis of exposure keratopathy in intensive care patients
Elem Kocaçal Güler (2018)
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndrome.
A. Alunno (2018)
10.3390/diagnostics10040208
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?
D. Sambataro (2020)
10.14260/jemds/2019/802
A Study of Prevalence and Association of Dry Eye Disease with Visual Display Terminal Use in Children- A Cross Sectional Observational Study
P. Sodani (2019)
10.3390/ijerph16183229
Achyranthis radix Extract Improves Urban Particulate Matter-Induced Dry Eye Disease
Tae Gu Lee (2019)
10.1109/HIC.2017.8227587
Label-free detection of lactoferrin and beta-2-microglobuin in contrived tear film using a low-cost electrical biosensor chip
M. Khan (2017)
10.1021/acsnano.8b04348
Label-Free Detection of Tear Biomarkers Using Hydrogel-Coated Gold Nanoshells in a Localized Surface Plasmon Resonance-Based Biosensor.
Heidi R Culver (2018)
10.1016/j.ab.2020.113902
Fluorescent Contact Lens for Continuous Non-invasive Measurements of Sodium and Chloride Ion Concentrations in Tears.
R. Badugu (2020)
10.1016/j.transci.2015.05.015
Serum eye drop preparation in Australia: Current manufacturing practice.
D. Marks (2015)
Evaluation of patients with dry eye disease for conjunctival and 窑
()
10.1111/vox.12502
Serum eye drops: a survey of international production methods
D. Marks (2017)
10.1016/j.jtos.2017.01.001
Epidemiology of dry eye disease in Africa: The sparse information, gaps and opportunities.
A. E. Osae (2017)
10.1155/2016/8013621
Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease
L. Tian (2016)
10.1097/IIO.0000000000000176
New Diagnostics in Ocular Surface Disease
Katherine Kostroun (2017)
10.18231/j.ijooo.2020.020
Prevalence of dry eye in computer users
B. Reshma (2020)
10.1142/S0219519417400103
PERFORMANCE EVALUATION OF DRY EYE DETECTION SYSTEM USING HIGHER-ORDER SPECTRA FEATURES FOR DIFFERENT NOISE LEVELS IN IR THERMAL IMAGES
V. Sudarshan (2017)
10.25289/ml.2019.8.2.50
Effects of Low-level Light Therapy at 740 nm on Dry Eye Disease In Vivo
Hyeyoon Goo (2019)
10.3390/jcm8081227
Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits
Yu-Kai Kuo (2019)
10.1016/j.trsl.2018.04.002
Phosphosulindac is efficacious in an improved concanavalin A‐based rabbit model of chronic dry eye disease
R. Honkanen (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar